21-Gene Oncotype DX® Recurrence-Score benefits and application in elderly breast cancer patients


E. D. Chiru
Cantonal Hospital Baselland

Acquired aplastic anemia shows increased Nestin+ niches, upregulation of genes of the adaptive immune system and of CXCL12 in transformation


A. Beerlage
University Hospital Basel

Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: a single-center cross-sectional study


K. Vrotniakaite-Bajerciene
University Hospital of Bern, University of Bern

A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: a prospective, multicenter, observational study


H. Nilius
University Hospital of Bern

A model of care using patient-reported outcomes for remotely managing symptoms of cancer patients treated with immune checkpoint inhibitors


A. da Silva Lopes
Lausanne University Hospital

Analysis of cell types in apheresis material for CAR-T therapy: focus on patients with low CD3 counts


E. Moutzouri Beifuss
University Hospital of Bern

Analysis of manufacturing failures and out-of-specification products of tisa-cel: focus on low pre-apheresis CD3+ count


I. Chanias
University Hospital of Bern

A national Platform for allocation of CAR T-cell Therapy to Multiple Myleoma Patients


K. Baur
University Hospital Basel

anti-CD117 CAR T-cells in in vitro models of Advanced Forms of Systemic Mastocytosis


A. Kaiser
University Hospital Zurich

A predictive model based on thrombin generation to manage postpartal bleeding in healthy women and those with inherited bleeding disorders


J. Brodard
University Hospital of Bern

ASCENT-03: Phase 3 study of sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in first-line (1L) metastatic triple-negative breast cancer (mTNBC)


J. Huober
Cantonal Hospital St. Gallen, University of Ulm

ASCENT-04/KEYNOTE-D19: Phase 3 study of sacituzumab govitecan (SG) plus pembrolizumab (pembro) vs treatment of physician’s choice (TPC) plus pembro in 1L programmed death-ligand 1-positive (PD-L1+) metastatic triple-negative breast cancer (mTNBC)


J. Huober
Cantonal Hospital St. Gallen, University of Ulm

BeEAM conditioning before autologous stem cell transplantation is safe and effective in patients with Waldenstrom’s Macroglobulinemia


P. Beck
University Hospital of Bern

BeEAM with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL


T. Stoffel
University Hospital of Bern

B-NHL screening in patients with newly diagnosed monoclonal gammopathies


K. Mayr
Viollier AG

CAR-T cell therapy for a patient with active hepatitis B - a case report: practical aspects and review of literature


M. Schöppenthau
Inselspital, Bern University Hospital, University of Bern

Clinical symptoms, quality of life and treatment effects during oncological indoor rehabilitation


H. G. Hass
Institut für Rehabilitationsforschung und Survivorship (IREFOS), Klinik Gais

CONGENITAL DYSFIBRINOGENEMIA COMBINED WITH ANTITHROMBIN AND FACTOR V POLYMORPHISMS RESULTING IN INCREASED THROMBIN GENERATION AND ABNORMAL FIBRIN CLOT STRUCTURE


B. Baráth
University of Geneva

Contact x-ray radiotherapy (Papillon) to improve complete response and organ preservation in early rectal cancer


C. Picardi
Hirslanden Hospital, Swiss Medical Network, Swiss Oncology Network

Decreased plasma protein S improves hemostasis in F12 deficient mice


M. Tripodo
University Hospital of Bern, University of Bern

Development of a reference model for Patient and Public Involvement in oncology research in French-speaking Switzerland


S. Colomer-Lahiguera
Institute of Higher Education and Research in Healthcare-IUFRS, University of Lausanne, Lausanne University Hospital, Lausanne University Hospital

Diffuse fibroblastic reticular cell tumor of the bone: a case report


M. Bertschinger
Cantonal Hospital Winterthur

Durable Efficacy of Selpercatinib in Patients (pts) with Medullary Thyroid Cancer (MTC): Update of the LIBRETTO-001 Trial


M. Kroiss
University Hospital Munich, University Hospital Würzburg

Effect of pharmacokinetics and pharmacogenomics in adults with Allogeneic Hematopoietic Cell Transplantation conditioned with Busulfan


C. Seydoux
Lausanne University Hospital, University Hospital Basel

Efficacy and safety by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in HR+, HER2- early breast cancer


S. Paluch-Shimon
Hadassah University Hospital

Evaluation of the implementation of the Symptom Navi Programme, a nurse-led intervention supporting cancer outpatient self-management


M. Bana
Formation and Training, University of Applied Science and Arts HES-SO

Expansion of phenotypically senescent CD57+ CD8 T cells is associated with impaired immunocompetence after allogeneic hematopoietic stem cell transplantation


S. Morin
Geneva University Hospital

Expansion of phenotypically senescent CD57+ CD8 T cells is associated with impaired immunocompetence after allogeneic hematopoietic stem cell transplantation


S. Morin
Geneva University Hospital

Exploring direct drug targets, drug-associated pathways and the tumor microenvironment using mass cytometry-based predictive biomarker analysis for precision oncology (a TumorProfiler sub analysis)


A. Ring
University Hospital Zurich

Fibrinogen replacement in hereditary dysfibrinogenemia: how much is enough?


F. Casalino
University of Geneva

GAS6 and TAM receptors as biomarkers for disease severity in patients with COVID-19


J. S. Schneider
University Hospital of Bern, University of Bern

G-CSF Use in Isolated Severe Neutropenia. A monocentric retrospective Study.


L. Njue
University Hospital of Bern

Global coagulation assays capture the hemostatic status of Hemophilia A and B patients


D. Bertaggia Calderara
Lausanne University Hospital

Hemophagocytic Syndrome in Adults - Real-World data on Mortality from a tertiary reference center


T. Wojtovicova
University Hospital of Bern

HEPATIC GRANULOMATOSIS WITH REGENERATIVE NODULAR HYPERPLASIA AS A RARE PRESENTATION OF MULTIPLE MYELOMA - A CASE REPORT


P. Stakia
Geneva University Hospital

HHV-8 positive Kaposi sarcoma and suspected coexistent multicentric Castleman disease following allogeneic hematopoietic stem cell transplantation: a case report


E. Laspa
Geneva University Hospital

High incidence of intracranial haemorrhage in children with hereditary afibrinogenaemia


M. Abdelwahab
Cairo University Paediatric Hospital

Human pegivirus-1 replication is associated with impaired NK cell reconstitution after allogeneic haematopoietic stem cell transplantation


A. Pradier
Geneva University Hospital, University of Geneva

Identification of key regulators of procoagulant COAT platelet generation by quantitative phosphoproteomic analysis


L. Veuthey
Lausanne University Hospital

Identification of susceptibility to macrophage-based therapies in acute myeloid leukemia


V. Lysenko
University Hospital Zurich

Immune-reconstitution of GM-CSF-producing CD4 T cells after allogeneic hematopoietic stem-cell transplantation.


C. Bernardi
Geneva University Hospital, University of Geneva

Incidence and Risk Factors of Neutropenic Enterocolitis after Myelosuppressive Chemotherapy


C. Seydoux
Lausanne University Hospital, University Hospital Basel

Increased CIP2A-TOPBP1 interaction and filament formation in BRCA deficient mitotic breast- and ovarian cancer cells


P. Brasier-Lutz
University Hospital Zurich, University of Zurich

In-depth analysis of CD34pos hematopoietic stem and precursor cell (HSPC) subpopulations by flow cytometry using a single 20-color panel


A. Dufour
Geneva University Hospital

Large pharmacological screen to improve responses to dual PI3K/BCL2 inhibition in lymphomas


A. J. Arribas
University Svizzera Italiana

Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients


M. Maechler
University Hospital of Bern

Minimal residual disease monitoring by Ig/TCR rearrangement predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia


M. Medinger
University Hospital Basel

Mocravimod, a S1P receptor agonist, increases both T cell counts in bone marrow biopsies from patients undergoing allogeneic HCT and acute GvHD-freedom probability


M. Medinger
University Hospital Basel

Multi-system Langerhans cell histiocytosis (MS-LCH): Clinical resistance associated with class 3 MAP2K1 (MEK1) Mutation in adult patients


W. Rösler
University Hospital Zurich

Outcome of patients with multiple myeloma receiving allogeneic hematopoietic stem cell transplantation in the pre-CAR T cell era


C. de Ramón Ortiz
Geneva University Hospital

Outcomes of Matched Related Donor Hematopoetic Cell Transplantation with Reduced Intensity Conditioning in Hemoglobinopathies - a Single Center Experience


M. Klink
University Children’s Hospital

PATIENT, CAREGIVER, AND HEALTHCARE PROFESSIONAL EXPERIENCE IN ADOPTIVE CELL THERAPIES: AN EXPERIENCE-BASED CO-DESIGN STUDY


N. Graber
Lausanne University Hospital

Pegylated liposomal doxorubicin (PLD) in daily practice – A single center experience in elderly and co-morbid patients with metastatic breast cancer


T. Wallrabenstein
University Hospital Basel, University Medical Center Freiburg

Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors


M. Schneider
Swiss Group for Clinical Cancer Research (SAKK), University Hospital Zurich

Physiological correction of hereditary hypofibrinogenemia during pregnancy


R. Marchi
Geneva University Hospital, University of Geneva

Pitfalls of measuring thrombingeneration and chromogenic anti-Xa in presence of polybrene


K. Vrotniakaite-Bajerciene
University Hospital of Bern, University of Bern

Platelet concentrate without agitation prior to transfusion are effective in patients with acute myeloid leukemia or myelodysplastic syndrome


N. Dietliker
University Hospital Zurich

Predictive factors for thrombophilia diagnosis: a single-center cross sectional study


S. Najaf Zadeh
University Hospital of Bern

Predictors of the adoption of guideline-based end-of-life and BEreavement SupporT for families in cancer care (BEST Care study)


M. Riguzzi
University Hospital Zurich, University of Zurich

Pregnancy in chronic idiopathic neutropenia. A monocentric retrospective study.


L. Njue
University Hospital of Bern

Pre-operative anticoagulation management in patients with direct oral anticoagulation (DOAC) therapy


A. Mach
Geneva University Hospital

Proteomic profiling to identify new biomarkers for heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study


H. Nilius
University Hospital of Bern

PSMAddition: a phase 3 trial to compare treatment with 177Lu-PSMA-617 plus SOC versus SOC alone in patients with metastatic HSPC


D. Berthold
Lausanne University Hospital

PSMAfore: a phase 3 study comparing 177Lu-PSMA-617 treatment with change in androgen receptor pathway inhibitor in taxane-naïve patients with mCRPC


A. Lorch
University Hospital Zurich

Real-world analysis of outcomes of first-line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)


N. Zellweger
University Hospital Basel

Recurrent venous thromboembolic disease in a patient with severe congenital factor XIII deficiency.


L. Bounaix
Geneva University Hospital

Reimbursement of Car-T-Cell therapies in Switzerland - A single center experience


R. Saxer
Inselspital, Bern University Hospital, University of Bern

RIB-ELLE: Ribociclib + aromatase inhibitor/fulvestrant in HR+, HER2- advanced breast cancer in the real-world Swiss population: 1st interim analysis


R. Popescu
Tumor Zentrum Aarau, Aarau, Switzerland

SAKK 16/14 – Peripheral immune cell populations in response to neoadjuvant durvalumab in patients with stage IIIA(N2) NSCLC


D. Schmid
University Hospital Basel

SEM and 3D reconstruction of ex-vivo arterial thrombi: a pilot study


B. Baráth
University of Geneva

SEM AND 3D RECONSTRUCTION OF EX-VIVO ARTERIAL THROMBI: A PILOT STUDY


B. Baráth
University of Geneva

Significance of the Src homology 2 domain-containing phosphatase SHP2 in engaging MAPK pathway activation in myeloproliferative neoplasms


S. Jungius
University Hospital Basel

Single cell genotyping of matched stem/progenitor and mature blood cells in treatment naive and AZA-treated MDS and CMML reveals significant contribution of mutated clones to blood production


A. Schnegg-Kaufmann
University Hospital of Bern, University of New South Wales

Single-center experience with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma


D. Akhoundova Sanoyan
University Hospital of Bern

Single-Center Experience with Emicizumab (Emi) in adult patients with severe Hemophilia A (PwHA): Thrombin generation, Emicizumab-levels and Interventions.


J. S. Schneider
University Hospital of Bern, University of Bern

SMAD1 is a silenced tumor suppressor in AML with MLL rearrangement


L. Dietsche
University Hospital Zurich

Software development to quantify fibrin clot images by laser scanning confocal microscopy (LSCM)


R. Marchi
Geneva University Hospital, University of Geneva

SwissCanOn – scientific patient registry for medicinal cannabis in oncology including ePROs – Trial in Progress


A. Trojan
Seespital Horgen

Targeting PI3K signaling is a potential therapeutic strategy in Clear Cell Sarcoma


L. P. Leuenberger
University Hospital Zurich

Taxane first or pegylated liposomal doxorubicin (PLD)? A retrospective analysis of PLD-taxane versus taxane-PLD in patients with metastatic breast cancer.


T. Wallrabenstein
University Hospital Basel, University Medical Center Freiburg

The Contribution of Mitochondrial Calcium Homeostasis in ADP-Evoked Platelet Responses


D. Shehwar
Lausanne University Hospital, Quaid-i-Azam University

The role of immunotherapies in real-word: an analysis of the treatment patterns, survival and toxicity of immune checkpoint inhibitors by sex


M. N. Wahli
Inselspital

Treatment and outcomes of patients with post-transplant lymphoproliferative disorder: a single centre experience


C. de Ramón Ortiz
Geneva University Hospital

Triple alloimmunization against leuco-platelet antigens and a successful allogenic hematopoietic stem cell transplantation


E. Royston
Geneva University Hospital

ULK1 inhibition preferentially targets Germinal Centre B-cell Lymphoma subtype by attenuating autophagy, C-MYC and inflammation


H. Mandhair
University of Bern

Unraveling HRDness and therapeutic opportunities in sarcoma


L. Planas-Paz
University Hospital Zurich

Use of andexanet alfa for direct oral anticoagulant reversion: a retrospective study in a tertiary hospital


E. Laspa
Geneva University Hospital

Use of global coagulation assays to monitor emicizumab pharmacodynamics


D. Bertaggia Calderara
Lausanne University Hospital

Von Willebrand factor (vWF) is involved in thrombophilia of severe COVID-19: in situ evidence from autopsies


J. van den Berg
University Hospital Basel

Which patients with advanced non-small cell lung cancer (NSCLC) benefit from combined immuno-chemotherapy? A single-center retrospective study.


M. Mamot
University of Basel
Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.